biocryst, Author at Biocryst - Page 9 of 10

Plasma kallikrein-kinin system and diabetic retinopathy

View Article

biocryst

January 27, 2025

Diabetic Macular Edema (DME)
The evolving therapeutic landscape of diabetic retinopathy

View Article

biocryst

January 27, 2025

Diabetic Macular Edema (DME)
Mechanisms of macular edema

View Article

biocryst

January 27, 2025

Diabetic Macular Edema (DME)
Diabetic Macular Edema: Current Understanding, Molecular Mechanisms and Therapeutic Implications

View Article

biocryst

January 27, 2025

Diabetic Macular Edema (DME)
Mechanisms of macular edema: Beyond the surface

View Article

biocryst

January 27, 2025

Diabetic Macular Edema (DME)
Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory

View Article

biocryst

January 27, 2025

Diabetic Macular Edema (DME)
Hereditary angioedema in children: Review and practical perspective for clinical management

biocryst

December 10, 2024
Androgen transition and management of hereditary angioedema long-term prophylaxis in real life: a single-center case series

biocryst

July 9, 2024

Hereditary Angioedema (HAE)
Hereditary angioedema outcomes in US patients switched from injectable long-term prophylactic medication to oral berotralstat

biocryst

April 1, 2024
Clinical Experience with Berotralstat in Patients with Hereditary Angioedema with Normal C1-Esterase Inhibitor: A Commented Case Series

View Article

biocryst

February 23, 2024

Hereditary Angioedema (HAE)